Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Accenture
Novartis
AstraZeneca
Julphar
Queensland Health
Argus Health
Fish and Richardson
Cerilliant
Mallinckrodt

Generated: October 21, 2017

DrugPatentWatch Database Preview

Heyl Chemisch Company Profile

« Back to Dashboard

What is the competitive landscape for HEYL CHEMISCH, and what generic and branded alternatives to HEYL CHEMISCH drugs are available?

HEYL CHEMISCH has one approved drug.



Summary for Applicant: Heyl Chemisch

US Patents:0
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Heyl Chemisch
RADIOGARDASE (PRUSSIAN BLUE)
ferric hexacyanoferrate(ii)
CAPSULE;ORAL021626-001Oct 2, 2003RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Novartis
Dow
Express Scripts
Argus Health
Medtronic
Teva
US Department of Justice
Cerilliant
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot